GMP Flexibility For Compounders Signaled In FDA Draft Guidance / Agency seeks comments on how to minimize burden of some testing requirements for registered outsourcing facilities. / “The Pink Sheet” DAILY July 1 2014 5:25 PM
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
No comments:
Post a Comment